Inicio › Cáncer de pulmón de células no pequeñas › Illinois › Arlington Heights
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Arlington Heights, IL
12 estudios para Cáncer de pulmón de células no pequeñas buscan participantes en centros de Arlington Heights y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- Advocate Good Shepherd Hospital, Barrington · A 9 mi de distancia
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
ReclutandoFase 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
ReclutandoFase 3
- Illinois Cancer Specialists, Arlington Heights
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
ReclutandoEstudio observacional
- Northwest Oncology & Hematology, Elk Grove Village · A 6 mi de distancia
An External Control Arm Study in Non-Small Cell Lung Cancer
ReclutandoEstudio observacional
- Northwest Oncology and Hematology, Rolling Meadows · A 2 mi de distancia
- Northwest Oncology and Hematology, Elk Grove · A 6 mi de distancia
- Northwest Oncology and Hematology, Hoffman Estates · A 6 mi de distancia
- y 1 más
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
ReclutandoFase 2/3
- Local Institution - 007-883-A, Arlington Heights
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
ReclutandoFase 3
- Illinois Cancer Specialists, Arlington Heights
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
ReclutandoFase 3
- Northwest Oncology & Hematology, Barrington · A 9 mi de distancia
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- Advocate Good Shepherd Hospital, Barrington · A 9 mi de distancia
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- Advocate Good Shepherd Hospital, Barrington · A 9 mi de distancia
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- Advocate Good Shepherd Hospital, Barrington · A 9 mi de distancia
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Advocate Good Shepherd Hospital, Barrington · A 9 mi de distancia
Ensayos de Cáncer de pulmón de células no pequeñas en otras ciudades
- Houston, TX145 estudios
- New York City, NY121 estudios
- Arlington, VA104 estudios
- Nashville, TN97 estudios
- Boston, MA90 estudios
- Los Angeles, CA87 estudios
- St. Louis, MO73 estudios
- Chicago, IL61 estudios
- Baltimore, MD60 estudios
- San Antonio, TX59 estudios
- Columbus, OH57 estudios
- Washington, DC55 estudios
Otros estudios en Arlington Heights
- Cáncer del colon y del recto12 estudios
- Cáncer de pulmón9 estudios
- Cáncer de seno7 estudios
- Fallo cardíaco7 estudios
- Cáncer metastásico6 estudios
- Colitis ulcerativa6 estudios
- Cáncer de colon6 estudios
- Cáncer de ovario5 estudios
- Obesidad5 estudios
- Sobrepeso5 estudios
- Cáncer de próstata3 estudios
- Enfermedades de la piel3 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.